EPE0886 Cost-effectiveness of three different Pre-Exposure Prophylaxis (PrEP) regimens for HIV prevention in MexicoE-posterCosting, cost effectiveness and affordability
EPE0885 Cost-effectiveness of treating anal pre-cancerous lesions among gay, bisexual and other men who have sex with men living with HIVE-posterCosting, cost effectiveness and affordability
EPA0052 Costimulation with MAdCAM and retinoic acid generates the formation of gut tissue resident memory CD8 T cells that express E-cadherinE-posterHost immune responses, vaccines and immunotherapies
OALBE0603 Costs and cost-effectiveness of immediate initiation of antiretroviral therapy upon diagnosis of HIV (Rapid Start) in the United StatesOral abstract session with live Q&ACosting, cost effectiveness and affordability
EPC0501 Country program-level association between timing of maternal ART initiation and vertical HIV transmission rates in 15 PEPFAR-supported programsE-posterCascades of HIV care and treatment
MOPED03 Couple dynamics, risk perception and interest for a multipurpose prevention product for HIV and pregnancy preventionPoster exhibitionSocial science theories, concepts and methods
EPE0782 Coverage of early infant diagnosis in Liberia - a quality improvement experienceE-posterImplementation science and scale up of HIV testing
EPC0523 COVID 19 Lethality in people living with HIV at the Mexican Institute of Social Security. Result from an observational cohortE-posterEpidemiology of COVID-19
EPA0096 COVID -19 vaccination uptake among adolescents and young people living with HIV in Kenya, 2021-2022E-posterSARS-CoV-2 virology, pathogenesis, and host immune responses, vaccines and immunotherapies
TUPED23 COVID-19 associated psychosocial outcomes among Black women with HIV affected by interpersonal violence participating in an mHealth HIV intervention in California, USAPoster exhibitionSocial and behavioural aspects and approaches to COVID-19
311 - 320 of 1427 items